Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Deficit Accumulated
Beginning balance (in shares) at Dec. 31, 2022		10,518,539
Beginning balance at Dec. 31, 2022	$ 18,111	$ 11	$ 153,872	$ (135,772)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash (in shares)		43,161
Issuance of common stock for cash	44		44
Stock-based compensation	446		446
Net Income (Loss)	(7,636)			(7,636)
Ending balance (in shares) at Mar. 31, 2023		10,561,700
Ending balance at Mar. 31, 2023	10,965	$ 11	154,362	(143,408)
Beginning balance (in shares) at Dec. 31, 2023		22,045,255
Beginning balance at Dec. 31, 2023	26,768	$ 22	192,009	(165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in Connection with at the market offering (net of issuance costs of $8), shares		56,288
Issuance of common stock in Connection with at the market offering (net of issuance costs of $8)	253		253
Issuance of common stock under equity plan awards (in shares)		115,722
Issuance of common stock under equity plan award	197		197
Stock-based compensation	1,318		1,318
Net Income (Loss)	(7,904)			(7,904)
Ending balance (in shares) at Mar. 31, 2024		22,217,265
Ending balance at Mar. 31, 2024	$ 20,632	$ 22	$ 193,777	$ (173,167)